Annotation Detail for AGBL2
Basic Information
Top
| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of AGBL2 mRNA | decreases expression | 20106945
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
2.88 | 12371664 |
| MESH:D002779 |
Cholestasis |
|
Cyclosporine |
3.32 | 19486331 |
| MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
3.48 | 19224547 |
| MESH:D005355 |
Fibrosis |
|
Cyclosporine |
4.05 | 12168785 12639820 |
| MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
5.31 | 8708960 |
| MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
5.51 | 15720958 |
| MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.25 | 10903974 |
| MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
5.86 | 15604871 |
| MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.61 | 18776723 10903974 8314463 |
| MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
3.22 | 12371664 |
| MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
6.20 | 16801185 |
| MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
5.86 | 17954296 |
| MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.81 | 18481113 19348381 |
| MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.75 | 12371664 |
| MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.36 | 16882103 |
| MESH:D014605 |
Uveitis |
|
Cyclosporine |
5.40 | 1336536 |
| MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
5.86 | 17120751 |
Related Pathway Information